The role of midtrimester targeted fetal organ screening combined with the “triple test” and maternal age in the diagnosis of trisomy 21: A retrospective study
- 31 January 1998
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 178 (1) , 40-44
- https://doi.org/10.1016/s0002-9378(98)70623-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonographyAmerican Journal of Obstetrics and Gynecology, 1995
- Second‐trimester maternal serum screening using alpha‐fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: Experience of a regional programmePrenatal Diagnosis, 1994
- Evaluation of routine prenatal ultrasound examination in detecting fetal chromosomal abnormalities in a low risk populationHuman Genetics, 1993
- Ultrasonographically detectable markers of fetal chromosomal abnormalitiesThe Lancet, 1992
- Sonographic scoring index for prenatal detection of chromosomal abnormalitiesJournal of Ultrasound in Medicine, 1992
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992
- Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.BMJ, 1992
- Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.BMJ, 1992
- Sonographic recognition of major malformations and aberrant fetal growth in trisomic fetuses.Journal of Ultrasound in Medicine, 1991
- Ultrasonographic detection of the second-trimester fetus with trisomy 18 and trisomy 21American Journal of Obstetrics and Gynecology, 1990